0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

La catatonie expérimentale par la bulbocapnine: Étude physiologique et clinique.

JAMA. 1931;97(3):202. doi:10.1001/jama.1931.02730030052034.
Text Size: A A A
Published online

ABSTRACT

This interesting monograph has a preface by H. Claude and B. Brouwer, who call attention to its importance. De Jong and Baruk discuss their results and opinions based on their individual work and that combined with other workers. Following an introduction which forecasts the contents of the monograph, the authors describe the chemistry of bulbocapnine, an alkaloid derived from a species of Corydalis, Corydalis cava, or bulbocapnus cavum, which has a chemical similarity to apomorphine. In 1904 Peters observed the immobilizing action of this drug. In 1921 de Jong, following some plethysmographic studies in catatonia in man, began his experiments on this drug. The authors then discuss the physiology of the drug and report on its action on medullary, decerebrated, thalamic, striate and normal animals; animals without a neocortex, as fish, frogs and reptiles; animals with a rudimentary neocortex, as fowl; and animals with a developed neocortex, as mammals. They

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();